---
figid: PMC7690430__cells-09-02342-g003
figtitle: Targeting the PI3K–AKT–mTOR pathway to treat prostate cancer
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC7690430
filename: cells-09-02342-g003.jpg
figlink: pmc/articles/PMC7690430/figure/cells-09-02342-f003/
number: F3
caption: Targeting the PI3K–AKT–mTOR pathway to treat prostate cancer. Image shows
  small-molecule inhibitors that target key components of the PI3K–AKT–mTOR signaling
  pathway that have recently been investigated in the clinic to treat prostate cancer.
  4EBP1, Eukaryotic translation initiation factor 4E-binding protein 1; AKTi, AKT
  inhibitor; DNA-PKi, DNA-dependent protein kinase inhibitor; GPCR, G-protein coupled
  receptor; mTORC1/2, mammalian target of rapamycin complex 1/2; mTORC1i, mTORC1 inhibitor,
  mTORC1/2i, mTORC1/2 inhibitor, P, phosphorylation event; Pan-PI3Ki, pan-PI3K inhibitors;
  PDK1, phosphoinositide-dependent kinase 1; PI3K, phosphoinositide 3-kinase; PIP2,
  phosphatidylinositol 4,5-bisphosphate; PIP3, phosphatidylinositol 3,4,5-trisphosphate;
  RTK, receptor tyrosine kinase; S6K, p70 ribosomal S6 kinase; TSC1, tuberous sclerosis
  complex 1; TCS2, tuberous sclerosis complex 2.
papertitle: 'The PTEN Conundrum: How to Target PTEN-Deficient Prostate Cancer.'
reftext: Daniel J. Turnham, et al. Cells. 2020 Nov;9(11):2342.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.957181
figid_alias: PMC7690430__F3
figtype: Figure
redirect_from: /figures/PMC7690430__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7690430__cells-09-02342-g003.html
  '@type': Dataset
  description: Targeting the PI3K–AKT–mTOR pathway to treat prostate cancer. Image
    shows small-molecule inhibitors that target key components of the PI3K–AKT–mTOR
    signaling pathway that have recently been investigated in the clinic to treat
    prostate cancer. 4EBP1, Eukaryotic translation initiation factor 4E-binding protein
    1; AKTi, AKT inhibitor; DNA-PKi, DNA-dependent protein kinase inhibitor; GPCR,
    G-protein coupled receptor; mTORC1/2, mammalian target of rapamycin complex 1/2;
    mTORC1i, mTORC1 inhibitor, mTORC1/2i, mTORC1/2 inhibitor, P, phosphorylation event;
    Pan-PI3Ki, pan-PI3K inhibitors; PDK1, phosphoinositide-dependent kinase 1; PI3K,
    phosphoinositide 3-kinase; PIP2, phosphatidylinositol 4,5-bisphosphate; PIP3,
    phosphatidylinositol 3,4,5-trisphosphate; RTK, receptor tyrosine kinase; S6K,
    p70 ribosomal S6 kinase; TSC1, tuberous sclerosis complex 1; TCS2, tuberous sclerosis
    complex 2.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Oamb
  - Tie
  - Ras85D
  - InR
  - Pten
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Crtc
  - Pdk1
  - Tsc1
  - gig
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Thor
  - S6k
  - CycE
  - cyc
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - PTEN
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - AKT1
  - AKT2
  - AKT3
  - RPTOR
  - PDK1
  - PDPK1
  - TSC1
  - CCL26
  - TSC2
  - EIF4EBP1
  - RPS6KB1
  - Ser
  - BAY 80-69460
  - MLNO128
  - GDC-0980
  - BEZ235
  - LY3023414
  - BYL719
  - AZD8186
  - BAY1082439
  - GSK2636771
  - Everolimus
  - RADO01
  - Sirolimus
  - Rapamycin
  - Temsirolimus
  - Afuresertib
  - GSK2110183
  - AZD5363
  - MK-2206
  - Uprosertib
  - GSK2141795
---
